GGPeps timeline
Every GGPeps batch the index holds, newest manufacture date first, with the supplier's declared purity beside the median of the index's independent observations of the same lot.
| Lot | Compound | Manufactured | Quarter | Tests | Independent median | Spread (pp) | COA purity | Divergence (pp) | |
|---|---|---|---|---|---|---|---|---|---|
| GGPE-2606-E1234 | CJC-1295 (no DAC) | 02 Jun 2026 | 2026-Q3 | 6 | 98.14 | 0.57 | 98.45 | +0.31 | |
| GGPE-2605-B2560 | BPC-157 | 21 May 2026 | 2026-Q2 | 6 | 98.70 | 0.69 | 98.90 | +0.20 | |
| GGPE-2604-X3153 | Retatrutide | 30 Apr 2026 | 2026-Q2 | 3 | 98.00 | 0.33 | 98.14 | +0.14 | |
| GGPE-2604-K9879 | IGF-1 LR3 | 27 Apr 2026 | 2026-Q2 | 5 | 98.11 | 1.10 | 98.11 | 0.00 | |
| GGPE-2604-H1052 | Tirzepatide | 22 Apr 2026 | 2026-Q2 | 13 | 99.35 | 0.98 | 99.58 | +0.23 | |
| GGPE-2604-L2151 | Semaglutide | 20 Apr 2026 | 2026-Q2 | 4 | 99.00 | 0.79 | 98.92 | -0.08 | |
| GGPE-2604-U1472 | Retatrutide | 16 Apr 2026 | 2026-Q2 | 4 | 97.96 | 1.03 | 97.64 | -0.32 | |
| GGPE-2603-W1490 | Semaglutide | 30 Mar 2026 | 2026-Q2 | 3 | 99.78 | 0.59 | 99.85 | +0.07 | |
| GGPE-2603-R2320 | Cagrilintide | 27 Mar 2026 | 2026-Q2 | 1 | 98.13 | n<2 | 98.67 | +0.54 | |
| GGPE-2603-P1474 | Melanotan II | 27 Mar 2026 | 2026-Q3 | 6 | 99.24 | 0.39 | 99.10 | -0.14 | |
| GGPE-2603-J2447 | Selank | 15 Mar 2026 | 2026-Q3 | 2 | 98.90 | 0.05 | 99.14 | +0.24 | |
| GGPE-2602-E1411 | BPC-157 | 20 Feb 2026 | 2026-Q2 | 4 | 99.10 | 1.04 | 99.14 | +0.04 | |
| GGPE-2602-W2305 | ARA-290 | 18 Feb 2026 | 2026-Q1 | 1 | 98.87 | n<2 | 99.27 | +0.40 | |
| GGPE-2602-Y9952 | Semax | 15 Feb 2026 | 2026-Q2 | 8 | 99.40 | 0.87 | 99.20 | -0.20 | |
| GGPE-2602-N2621 | BPC-157 | 15 Feb 2026 | 2026-Q2 | 13 | 98.94 | 1.07 | 99.00 | +0.06 | |
| GGPE-2601-B2671 | TB-500 | 20 Jan 2026 | 2026-Q2 | 13 | 99.59 | 0.72 | 99.60 | +0.01 | |
| GGPE-2601-J3130 | Selank | 01 Jan 2026 | 2026-Q2 | 7 | 99.66 | 0.38 | 99.32 | -0.34 | |
| GGPE-2512-A2945 | N-Acetyl Semax Amide | 24 Dec 2025 | 2026-Q2 | 3 | 98.57 | 0.79 | 98.89 | +0.32 | |
| GGPE-2512-M2434 | 5-Amino-1MQ | 23 Dec 2025 | 2026-Q2 | 2 | 99.44 | 0.23 | 99.51 | +0.07 | |
| GGPE-2512-Y1048 | Semax | 21 Dec 2025 | 2026-Q2 | 12 | 99.41 | 0.96 | 99.35 | -0.06 | |
| GGPE-2512-D2133 | Retatrutide | 09 Dec 2025 | 2026-Q2 | 13 | 98.51 | 1.06 | 98.28 | -0.23 | |
| GGPE-2512-Y2660 | Survodutide | 04 Dec 2025 | 2026-Q2 | 14 | 97.66 | 1.31 | 97.46 | -0.20 | |
| GGPE-2511-R1308 | SLU-PP-332 | 30 Nov 2025 | 2026-Q2 | 4 | 98.93 | 0.79 | 98.92 | -0.01 | |
| GGPE-2511-F1016 | ARA-290 | 29 Nov 2025 | 2025-Q4 | 1 | 98.53 | n<2 | 99.25 | +0.72 | |
| GGPE-2511-X1174 | Semax | 25 Nov 2025 | 2026-Q1 | 1 | 99.59 | n<2 | 99.45 | -0.14 | SHARED BULK |
| GGPE-2511-Y3312 | Desmopressin | 24 Nov 2025 | 2025-Q4 | 2 | 99.29 | 0.30 | 99.59 | +0.30 | |
| GGPE-2511-K1569 | KPV | 22 Nov 2025 | 2026-Q2 | 1 | 98.40 | n<2 | 98.34 | -0.06 | |
| GGPE-2511-W2357 | Retatrutide | 20 Nov 2025 | 2026-Q1 | 5 | 98.01 | 1.29 | 98.12 | +0.11 | |
| GGPE-2511-S2270 | BPC-157 | 04 Nov 2025 | 2026-Q2 | 5 | 98.28 | 0.53 | 98.17 | -0.11 | |
| GGPE-2510-V2787 | Liraglutide | 31 Oct 2025 | 2026-Q1 | 3 | 98.77 | 0.44 | 98.67 | -0.10 | |
| GGPE-2510-C1819 | Semax | 28 Oct 2025 | 2025-Q4 | 2 | 99.05 | 0.19 | 99.42 | +0.37 | |
| GGPE-2510-R1919 | Retatrutide | 26 Oct 2025 | 2026-Q1 | 10 | 99.14 | 1.42 | 99.56 | +0.42 | |
| GGPE-2510-H2976 | Enclomiphene citrate | 19 Oct 2025 | 2025-Q4 | 3 | 99.93 | 0.00 | 99.74 | -0.19 | |
| GGPE-2510-C2712 | Liraglutide | 16 Oct 2025 | 2026-Q1 | 5 | 98.73 | 0.54 | 99.05 | +0.32 | |
| GGPE-2510-L2662 | Tirzepatide | 02 Oct 2025 | 2026-Q1 | 13 | 98.35 | 1.33 | 98.43 | +0.08 | |
| GGPE-2509-H1678 | Melanotan II | 18 Sep 2025 | 2026-Q1 | 2 | 99.03 | 0.38 | 99.45 | +0.42 | |
| GGPE-2509-N9693 | BPC-157 | 04 Sep 2025 | 2025-Q4 | 3 | 98.76 | 0.19 | 99.21 | +0.45 | |
| GGPE-2508-U1475 | Sermorelin | 30 Aug 2025 | 2025-Q4 | 1 | 99.64 | n<2 | 99.88 | +0.24 | |
| GGPE-2508-E2729 | Ipamorelin | 19 Aug 2025 | 2026-Q1 | 2 | 99.72 | 0.16 | 99.90 | +0.18 | |
| GGPE-2508-E1731 | Retatrutide | 12 Aug 2025 | 2025-Q3 | 10 | 97.98 | 1.25 | 98.02 | +0.04 | |
| GGPE-2507-S2892 | MK-677 (Ibutamoren mesylate) | 27 Jul 2025 | 2025-Q3 | 9 | 99.81 | 0.24 | 99.75 | -0.06 | |
| GGPE-2507-D1397 | CJC-1295 (no DAC) | 09 Jul 2025 | 2025-Q4 | 3 | 98.42 | 0.70 | 98.39 | -0.03 | |
| GGPE-2506-T1988 | MGF | 27 Jun 2025 | 2025-Q4 | 4 | 98.49 | 0.68 | 98.29 | -0.20 | |
| GGPE-2505-W2368 | Liraglutide | 25 May 2025 | 2025-Q4 | 11 | 98.80 | 1.16 | 99.03 | +0.23 | SHARED BULK |
| GGPE-2502-J1624 | Tirzepatide | 22 Feb 2025 | 2025-Q3 | 6 | 98.03 | 0.92 | 97.60 | -0.43 | |
| GGPE-2502-S2559 | BPC-157 | 10 Feb 2025 | 2025-Q1 | 11 | 98.81 | 1.18 | 99.61 | +0.80 | |
| GGPE-2502-W2287 | NAD+ | 09 Feb 2025 | 2025-Q2 | 2 | 98.70 | 0.10 | 98.84 | +0.14 | |
| GGPE-2501-B2246 | TB-500 | 19 Jan 2025 | 2025-Q1 | 1 | 98.96 | n<2 | 99.37 | +0.41 | |
| GGPE-2501-W1875 | Semaglutide | 08 Jan 2025 | 2025-Q1 | 12 | 98.43 | 1.84 | 98.51 | +0.08 | |
| GGPE-2501-J3047 | L-Glutathione (reduced) | 05 Jan 2025 | 2025-Q1 | 1 | 98.58 | n<2 | 98.40 | -0.18 | |
| GGPE-2412-M2779 | Tirzepatide | 08 Dec 2024 | 2025-Q2 | 4 | 98.11 | 1.01 | 98.67 | +0.56 | |
| GGPE-2411-V3137 | BPC-157 | 21 Nov 2024 | 2025-Q2 | 14 | 98.85 | 0.77 | 98.40 | -0.45 | |
| GGPE-2411-R9634 | Retatrutide | 19 Nov 2024 | 2024-Q4 | 5 | 99.16 | 0.40 | 98.82 | -0.34 | |
| GGPE-2411-R2490 | KPV | 06 Nov 2024 | 2025-Q2 | 1 | 98.58 | n<2 | 98.44 | -0.14 | |
| GGPE-2411-B1929 | Ipamorelin | 06 Nov 2024 | 2025-Q2 | 8 | 99.13 | 0.47 | 99.24 | +0.11 | |
| GGPE-2410-S2226 | Enclomiphene citrate | 30 Oct 2024 | 2025-Q1 | 13 | 98.27 | 1.20 | 98.60 | +0.33 | |
| GGPE-2410-U1820 | Cagrilintide | 11 Oct 2024 | 2024-Q4 | 2 | 98.75 | 1.51 | 98.89 | +0.14 | |
| GGPE-2410-U3109 | Hexarelin | 05 Oct 2024 | 2024-Q4 | 3 | 99.28 | 0.17 | 99.75 | +0.47 | |
| GGPE-2409-C1458 | Sermorelin | 11 Sep 2024 | 2024-Q4 | 7 | 98.49 | 0.83 | 98.28 | -0.21 | |
| GGPE-2408-G2525 | CJC-1295 (no DAC) | 26 Aug 2024 | 2025-Q1 | 6 | 98.49 | 1.05 | 98.61 | +0.12 | |
| GGPE-2408-Y2528 | Semaglutide | 20 Aug 2024 | 2024-Q3 | 4 | 98.16 | 0.30 | 98.30 | +0.14 | |
| GGPE-2406-F1736 | GHRP-2 | 24 Jun 2024 | 2024-Q4 | 10 | 99.15 | 0.48 | 99.14 | -0.01 | |
| GGPE-2405-A3279 | NAD+ | 08 May 2024 | 2024-Q4 | 10 | 98.05 | 0.84 | 98.81 | +0.76 | |
| GGPE-2404-K2899 | Retatrutide | 04 Apr 2024 | 2024-Q3 | 6 | 98.11 | 0.60 | 98.12 | +0.01 | |
| GGPE-2312-B1701 | Hexarelin | 05 Dec 2023 | 2024-Q2 | 2 | 98.95 | 1.75 | 99.26 | +0.31 |